Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.56%239.21B | 13.05%234.82B | 6.16%936.21B | 8.37%260.5B | 6.50%239.07B | 0.81%226.61B | 8.04%207.72B | 17.57%881.92B | 18.45%240.38B | 19.97%224.49B |
Cost of revenue | -5.83%72.46B | 11.52%78.62B | 9.12%311.09B | 12.37%86.81B | 11.40%76.07B | 5.42%76.95B | 5.94%70.5B | 17.11%285.07B | 23.99%77.25B | 9.43%68.29B |
Gross profit | 11.42%166.75B | 13.83%156.21B | 4.74%625.12B | 6.48%173.69B | 4.35%163B | -1.41%149.66B | 9.15%137.23B | 17.79%596.85B | 15.99%163.13B | 25.24%156.2B |
Operating expense | -26.49%123.85B | 12.25%128.59B | 41.50%581.17B | 42.01%169.12B | 19.83%128.63B | 63.48%168.48B | 41.02%114.56B | 13.46%410.73B | 22.03%119.09B | 15.03%107.35B |
Selling and administrative expenses | 6.91%119.07B | 9.25%118.83B | 12.53%473.23B | 15.61%132.32B | 10.90%119.27B | 8.65%111.38B | 13.28%108.77B | 17.63%420.55B | 16.33%114.46B | 19.26%107.55B |
-General and administrative expense | 6.91%119.07B | 9.25%118.83B | 12.53%473.23B | 15.61%132.32B | 10.90%119.27B | 8.65%111.38B | 13.28%108.77B | 17.63%420.55B | 16.33%114.46B | 19.26%107.55B |
Other operating expenses | -87.87%7.02B | 61.91%10.41B | 710.67%112.6B | 493.76%38.13B | 333.38%10.14B | 2,696.09%57.88B | 110.17%6.43B | -23.49%13.89B | 33.49%6.42B | -40.52%2.34B |
Total other operating income | 185.59%2.24B | 1.73%647M | -80.32%4.67B | -25.79%1.33B | -69.12%785M | -48.76%784M | -96.43%636M | 73.53%23.71B | -68.05%1.8B | 220.96%2.54B |
Operating profit | 328.01%42.9B | 21.84%27.61B | -76.38%43.96B | -89.63%4.57B | -29.65%34.37B | -138.59%-18.81B | -49.05%22.67B | 28.63%186.12B | 2.31%44.04B | 55.62%48.85B |
Net non-operating interest income (expenses) | 78.67%-646M | 60.99%-1.08B | -79.47%-7.74B | -55.17%-1.73B | -125.00%-270M | -67.39%-3.03B | -11.85%-2.77B | 3.83%-4.32B | -251.63%-1.11B | 136.23%1.08B |
Non-operating interest income | 15.81%784M | 109.98%1.09B | -33.63%2.56B | -21.78%686M | -48.40%629M | -35.28%677M | -27.44%521M | 185.71%3.86B | 130.18%877M | 224.20%1.22B |
Non-operating interest expense | -61.40%1.43B | -33.89%2.17B | 26.07%10.31B | 21.26%2.41B | 546.76%899M | 29.77%3.71B | 3.01%3.29B | 40.03%8.18B | 663.74%1.99B | -95.86%139M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 446.67%156M | 27.51%-137M | -172.91%-358M | -500.00%-4M | -200.84%-120M | -113.47%-45M | -610.81%-189M | -67.09%491M | -99.89%1M | -33.15%119M |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 293.75%42.41B | 33.93%26.4B | -80.33%35.85B | -93.39%2.84B | -32.11%33.98B | -146.30%-21.89B | -53.13%19.71B | 28.65%182.29B | -3.95%42.92B | 75.07%50.05B |
Income tax | 100.91%7.93B | 86.57%11.61B | -79.95%8.88B | -257.76%-16.65B | 7.46%15B | -29.98%3.95B | -56.04%6.22B | 42.58%44.3B | -38.04%10.55B | 244.34%13.96B |
Net income | 243.58%34.4B | -93.94%14.58B | 69.16%242.93B | -79.13%7.35B | -54.34%18.92B | -157.01%-23.96B | 865.47%240.61B | 23.84%143.61B | 25.33%35.24B | 63.52%41.43B |
Net income continuous operations | 233.46%34.48B | 9.64%14.79B | -80.45%26.97B | -39.81%19.48B | -47.42%18.98B | -162.05%-25.83B | -51.65%13.49B | 24.73%137.99B | 17.03%32.37B | 47.11%36.09B |
Net income discontinuous operations | -104.36%-82M | -100.09%-203M | 3,740.58%215.96B | -522.21%-12.13B | -101.18%-63M | 391.88%1.88B | 7,752.56%227.13B | 5.24%5.62B | 523.21%2.87B | 566.17%5.34B |
Noncontrolling interests | 0 | 0 | 100.55%363M | 0 | 635.71%309M | -12.90%54M | -20.61%181M | -36.96%29M | -27.27%48M | |
Net income attributable to the company | 241.75%34.4B | -93.94%14.58B | 69.12%242.57B | -79.12%7.35B | -54.29%18.92B | -157.80%-24.26B | 867.66%240.56B | 23.92%143.43B | 25.43%35.22B | 63.76%41.38B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 241.75%34.4B | -93.94%14.58B | 69.12%242.57B | -79.12%7.35B | -54.29%18.92B | -157.80%-24.26B | 867.66%240.56B | 23.92%143.43B | 25.43%35.22B | 63.76%41.38B |
Gross dividend payment | ||||||||||
Basic earnings per share | 251.83%29.82 | -93.48%12.51 | 76.57%199.91 | -70.39%8.32 | -51.47%15.84 | -159.57%-19.64 | 882.59%191.9 | 25.49%113.22 | 27.55%28.1 | 66.02%32.64 |
Diluted earnings per share | 251.58%29.77 | -93.48%12.49 | 76.37%199.44 | -70.44%8.29 | -51.50%15.81 | -159.64%-19.64 | 881.05%191.5 | 25.41%113.08 | 27.40%28.04 | 65.90%32.6 |
Dividend per share | 0 | 0 | 12.50%18 | 12.50%18 | 0 | 0 | 0 | 14.29%16 | 14.29%16 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |